Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -6.60% is 39% above its 5-year average of -10.74%, around the middle of its 5-year range (-16.12%–6.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 42.29% above its 12-month average of -11.44%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -6.60%.
RETURN ON EQUITY (ROE)
-6.60%
RETURN ON EQUITY (ROE) AVG TTM
-11.44%
RETURN ON EQUITY (ROE) AVG 3Y
-10.19%
RETURN ON EQUITY (ROE) AVG 5Y
-10.74%
RETURN ON EQUITY (ROE) AVG 10Y
-4.75%
RETURN ON EQUITY (ROE) AVG 15Y
-2.83%
RETURN ON EQUITY (ROE) AVG 20Y
-4.03%
CURRENT VS TTM AVG
+42.29%
CURRENT VS 3Y AVG
+35.18%
CURRENT VS 5Y AVG
+38.51%
CURRENT VS 10Y AVG
-38.87%
CURRENT VS 15Y AVG
-133.54%
CURRENT VS 20Y AVG
-63.79%
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 92 covered companies
CURRENT VS SECTOR MEDIAN
-157.71%
vs the sector median at left
NeoGenomics, Inc.
Market Cap
$472.39M
Return on Equity (ROE)
-6.60%
TTM Avg
-11.44%
3Y Avg
-10.19%
5Y Avg
-10.74%
Market Cap
$459.30M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$397.55M
Return on Equity (ROE)
-28.18%
TTM Avg
-0.06%
3Y Avg
10.58%
5Y Avg
10.58%
Market Cap
$41.03M
Return on Equity (ROE)
N/A
TTM Avg
-285.38%
3Y Avg
-206.98%
5Y Avg
-151.57%
Market Cap
$1.00B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$1.72B
Return on Equity (ROE)
-54.96%
TTM Avg
-60.50%
3Y Avg
-51.30%
5Y Avg
-42.73%
Market Cap
$1.73B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
Market Cap
$2.14B
Return on Equity (ROE)
-56.71%
TTM Avg
-50.91%
3Y Avg
-55.48%
5Y Avg
-35.68%
Market Cap
$2.51B
Return on Equity (ROE)
-8.00%
TTM Avg
-28.91%
3Y Avg
-27.68%
5Y Avg
-39.13%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeoGenomics, Inc. (NEO) | $472.39M | -6.60% | -11.44% | -10.19% | -10.74% |
| NRC Health (NRC)vs › | $459.30M | 89.43% | 81.07% | 67.39% | 61.90% |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | -28.18% | -0.06% | 10.58% | 10.58% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.03M | N/A | -285.38% | -206.98% | -151.57% |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -13.54% | -40.81% | -170.75% | -114.78% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.72B | -54.96% | -60.50% | -51.30% | -42.73% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | -40.41% | -45.75% | -30.11% | -18.95% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.14B | -56.71% | -50.91% | -55.48% | -35.68% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.51B | -8.00% | -28.91% | -27.68% | -39.13% |
| TransMedics Group, Inc. (TMDX)vs › | $2.74B | 29.28% | 27.86% | 4.54% | -12.45% |
ROE
-6.6%
ROA
-3.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -6.60% |
| 2026-03-31 | -11.97% |
| 2025-12-31 | -12.91% |
| 2025-09-30 | -13.54% |
| 2025-06-30 | -12.18% |
| 2025-03-31 | -8.73% |
| 2024-12-31 | -8.72% |
| 2024-09-30 | -8.56% |
| 2024-06-30 | -8.58% |
| 2024-03-31 | -9.12% |
| 2023-12-31 | -9.34% |
| 2023-09-30 | -10.17% |
| 2023-06-30 | -11.99% |
| 2023-03-31 | -12.89% |
| 2022-12-31 | -14.45% |
| 2022-09-30 | -16.12% |
| 2022-06-30 | -14.07% |
| 2022-03-31 | -3.32% |
| 2021-12-31 | -0.75% |
| 2021-09-30 | 4.29% |
| 2021-06-30 | 6.25% |
| 2021-03-31 | -1.30% |
| 2020-12-31 | 0.60% |
| 2020-09-30 | -0.74% |
| 2020-06-30 | -0.82% |
| 2020-03-31 | 0.68% |
| 2019-12-31 | 1.58% |
| 2019-09-30 | 0.42% |
| 2019-06-30 | 0.40% |
| 2019-03-31 | -0.13% |
| 2018-12-31 | 0.82% |
| 2018-09-30 | 2.38% |
| 2018-06-30 | 0.58% |
| 2018-03-31 | 0.87% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | -5.59% |
| 2017-06-30 | -3.55% |
| 2017-03-31 | -3.76% |
| 2016-12-31 | -3.07% |
| 2016-09-30 | -0.39% |
| 2016-06-30 | -0.42% |
| 2016-03-31 | -0.67% |
| 2015-12-31 | -1.06% |
| 2015-09-30 | -0.02% |
| 2015-06-30 | -0.30% |
| 2015-03-31 | 0.45% |
| 2014-12-31 | 1.87% |
| 2014-09-30 | 1.59% |
| 2014-06-30 | 9.22% |
| 2014-03-31 | 9.48% |
| 2013-12-31 | 9.36% |
| 2013-09-30 | 5.23% |
| 2013-06-30 | -4.18% |
| 2013-03-31 | -2.84% |
| 2012-12-31 | 0.72% |
| 2012-09-30 | 3.59% |
| 2012-06-30 | 11.97% |
| 2012-03-31 | 3.68% |
| 2011-12-31 | -19.96% |
| 2011-09-30 | -31.83% |
| 2011-06-30 | -52.20% |
| 2011-03-31 | -63.98% |
| 2010-12-31 | -105.36% |
| 2010-09-30 | -132.00% |
| 2010-06-30 | -91.54% |
| 2010-03-31 | -59.30% |
| 2009-12-31 | -39.74% |
| 2009-09-30 | -24.23% |
| 2009-06-30 | -48.89% |
| 2009-03-31 | -47.25% |
| 2006-12-31 | -237.40% |
| 2006-09-30 | -27.06% |
